Skip to main content

Find Clinical Trials

Home
Conditions
TDP-43 Proteinopathies

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies

Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Not Yet Recruiting

Efficacy and Safety of Deep Cervical Lymph Node-vein Bypass Surgery in ALS Amyotrophic Lateral Sclerosis

NCT06351735

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Efficacy and Safety, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis

NCT06391645

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Congenital Abnormalities, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Revealing Engagement Dynamics Among Semantic Dementia Patients

NCT06218732

Conditions: Brain Diseases, Central Nervous System Diseases, Dementia, +11 more
Locations: Power Life Sciences San Francisco, California, United States

View Trial Details

Not Yet Recruiting

Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients

NCT05423678

Conditions: ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Evaluation of the Early Use of the Pressure Relaxer in the Respiratory Impairment of Patients With Amyotrophic Lateral Sclerosis: Multicenter Randomized Controlled Study.

NCT05297487

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Investigation of Cannabinoid 2-receptor Expression in the Brain and Spine of ALS-patients Compared to Healthy Controls With PET (18F-RoSMALS)

NCT05880563

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Muskelzentrum/ALS-Clinic, Kantonsspital St. Gallen Sankt Gallen, Switzerland

View Trial Details

Completed

Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation

NCT01925196

Conditions: Amyotrophic Lateral Sclerosis, Brain Diseases, Central Nervous System Diseases, +14 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)

NCT07047209

Conditions: ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations: Nova Southeastern University Davie, Florida, United States

Northwestern Universsity Chicago, Illinois, United States

MGH Boston, Massachusetts, United States

View Trial Details

Completed

Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP

NCT05562960

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +9 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)

NCT00330681

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: Not specified

View Trial Details